[1]KHIMJI AK,ROCKEY DC.Endothelin and hepatic wound healing[J].Pharmacol Res,2011,63(6):512-518.
|
[2]RODRIGUEZ-PASCUAL F,BUSNADIEGO O,GONZALEZSANTAMARIA J.The profibrotic role of endothelin-1:is the door still open for the treatment of fibrotic diseases?[J].Life Sci,2014,118(2):156-164.
|
[3]YOU M,ROGERS CQ.Adiponectin:a key adipokine in alcoholic fatty liver[J].Exp Biol Med(Maywood),2009,234(8):850-859.
|
[4]CALIGIURI A,BERTOLANI C,GUERRA CT,et al.Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells[J].Hepatology,2008,47(2):668-676.
|
[5]NAZAL L,RIQUELME A,SOLIS N,et al.Hypoadiponectinemia and its association with liver fibrosis in morbidly obese patients[J].Obes Surg,2010,20(10):1400-1407.
|
[6]LIU Y,RAMEZANI-MOGHADAM M,GEORGE J,et al.Kupffer cells and sinusoidal endothelial cells mediate adiponectin-induced antifibrogenic effects on hepatic stellate cells[J].J Gastroenterol Hepatol,2009,24:a289-a290.
|
[7]SEO YS,SHAH VH.Pathophysiology of portal hypertension and its clinical links[J].J Clin Exp Hepatol,2011,1(2):87-93.
|
[8]LIM JY,OH MA,KIM WH,et al.AMP-activated protein kinase inhibits TGF-β-induced fibrogenic responses of hepatic stellate cells by targeting transcriptional coactivator p300[J].J Cell Physiol,2012,227(3):1081-1089.
|
[9]SHI-WEN X,CHEN Y,DENTON CP,et al.Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts[J].Mol Biol Cell,2004,15(6):2707-2719.
|
[10]OUCHI N,KIHARA S,ARITA Y,et al.Adiponectin,an adipocyte-derived plasma protein,inhibits endothelial NF-κB signaling through a cA MP-dependent pathway[J].Circulation,2000,102(11):1296-1301.
|
[11]KIM J,WENDE AR,SENA S,et al.Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy[J].Mol Endocrinol,2008,22(11):2531-2543.
|
1. | 张玉婷,施欢,李虤,沈波. FibroTouch联合GGT/PLT比值对诊断乙型肝炎肝纤维化的临床价值. 江西医药. 2022(02): 206-209+216 . ![]() | |
2. | 杜乔慧,吴克俭,王争争. GP73、GPR对慢性乙型肝炎患者肝硬化的诊断价值. 胃肠病学和肝病学杂志. 2022(07): 758-763 . ![]() | |
3. | 鲁荣华. 血清IL-2和IL-10对重度慢性乙型肝炎患者糖皮质激素治疗预后的评估价值. 中国卫生工程学. 2020(01): 83-85 . ![]() | |
4. | 毛桂芸,张永飞,郭延生,陶金忠. 山楂对围产期奶牛肝功能和血脂的影响. 中国奶牛. 2020(08): 36-39 . ![]() | |
5. | 陈晓玲,宋倩. 剪切波弹性成像和γ-谷氨酰转肽酶/血小板比用于诊断慢性乙型肝炎患者肝纤维化. 中国医学影像技术. 2020(10): 1499-1503 . ![]() | |
6. | 黄春明,杨湛,聂玉强,胡中伟,周永健,詹远京,郭家伟,余卫华. FibroScan联合GGT/PLT比值预测慢性乙型肝炎患者肝纤维化的初步探讨. 临床肝胆病杂志. 2019(02): 334-337 . ![]() | |
7. | 张小磊. 血清ALT、AST、GGT、HBV-DNA联合检测在慢性乙型肝炎病情评估中的应用. 内蒙古医学杂志. 2019(02): 211-212 . ![]() | |
8. | 尹国云. 瞬时弹性超声检测对蒙古族地区慢性乙型病毒性肝炎患者抗病毒治疗临床指导意义的研究. 世界复合医学. 2019(06): 90-92+114 . ![]() | |
9. | 黄春明,胡中伟,聂玉强,周永健,詹远京,郭家伟,余卫华. 无创诊断模式预测慢性乙型肝炎合并非酒精性脂肪肝患者肝纤维化的价值. 胃肠病学和肝病学杂志. 2019(08): 915-918 . ![]() | |
10. | 黄春明,杨湛,聂玉强,胡中伟,周永健,詹远京,郭家伟,余卫华. GGT/PLT比值对广东地区慢性乙型肝炎患者肝纤维化分期的预测价值. 临床肝胆病杂志. 2018(06): 1204-1208 . ![]() | |
11. | 李曼,李涛,刘振杰,曹永坚,钟伟国,余婷玉,何敏,徐宁. 以血清学指标比值为变量的肝纤维化诊断模型构建与评价. 山东医药. 2018(18): 17-20 . ![]() | |
12. | 李曼,张军,李涛,罗强,钟伟国,李嘉胜,徐宁. ADA/PLT、ALP/PLT比值对肝纤维化的诊断价值. 中国实验诊断学. 2017(11): 1923-1926 . ![]() |